Activity

Activity ID

2308

Expires

October 7, 2019

Format Type

Internet

CME Credit

5

Fee

$40-$50
CME Provider

American Society for Clinical Oncology

Description

The 2016 Annual Meeting Highlights Radiation Oncology is designed to help the busy radiation oncologist remain abreast of key scientific updates and cancer care strategies that relate to practice from the 2016 ASCO Annual Meeting. This expert-led course provides a comprehensive collection on an array of key topics from the 2016 Annual Meeting relevant to the radiation oncologist. In addition, this course may also benefit medical oncologists, fellows, and advanced practice providers.
In this section on Breast Cancer, information discussed focuses on the role of surgery for stage IV breast cancer, axillary lymph node dissection after positive sentinel lymph node biopsy, and identifying optimal margin status.
In this section on Gynecologic Cancer, information discussed focuses on the advances in hormonal and immunotherapy for ovarian and cervical cancer, identifying the molecular subtypes of endometrial cancer with novel subtypes.
In this section on Central Nervous System Tumors, information discussed focuses on the impact of temozolomide in management of radiotherapy in patients with GBM and non-1p19q codeleted anaplastic gliomas, as well as whole brain radiotherapy vs. a salvage SRS protocol in patients undergoing resection in 1-4 brain metastases.
In this section on Gastrointestinal (Colorectal) Cancer, information discussed focuses on the pros and cons of adding oxaliplatin with 5-FU and radiation for locally advanced rectal cancer, how HIV status affects prognosis in patients with anal cancer, and the impact of early versus late salvage surgery for recurrence of anal cancer.
In this section on Gastrointestinal (Non-colorectal) Cancer, information discussed focuses on the role of radiotherapy after preoperative chemotherapy, stereotactic body radiotherapy, and adjuvant therapy.
In this section on Genitourinary (Prostate) Cancer, information discussed focuses on the benefit of androgen deprivation in the setting of high dose radiation for localized prostate cancer, compares hypofractionated radiotherapy schedule to conventional fractionation, and discusses adjuvant chemotherapy post prostatectomy.
In this section on Thoracic, information discussed focuses on protons compared to photons for stage III NSCLC, stereotactic body radiation therapy for the management of metastatic lung cancer, and the benefits of radiation for limited metastatic non-small cell lung cancer.
In this section on Melanoma, information discussed focuses on survival and toxicity following immune checkpoint inhibition, and combined targeted therapy in metastatic melanoma.
In this section on Head and Neck Cancer, information discussed focuses on the application of new agents and combinations, clarification of post-op organs at risk, and the role of cetuxRT vs ChemoRT.

Diplomate Engagement

Correct answers to the post-test, recommended literature or other resources (presentation, audio/video, checklists, etc.)

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

Overall
-Review recent and emerging data from key studies
-Effectively communicate with colleagues and with patients regarding advances in radiation oncology science
-Incorporate knowledge gained pertaining to advances in cancer research into innovative management strategies to improve patient outcomes
Breast Cancer
-Review the role of surgery for stage IV breast cancer
-Determine when axillary lymph node dissection is necessary after positive sentinel lymph node biopsy
-Identify optimal margin status after lumpectomy for ductal carcinoma in situ (DCIS)
Gynecological Cancer
-Review advances in hormonal and immunotherapy treatments for ovarian and cervical cancer
-Identify molecular subtypes of endometrial cancer and relate prognosis to these novel subtypes
Central Nervous System Tumors
-Explain the impact of adding concurrent and adjuvant temozolomide to hypofractionated radiotherapy in GBM
-Explain the impact of adding adjuvant temozolomide to standard radiotherapy on patients with non-1p19q codeleted anaplastic gliomas
-Differentiate the outcomes of whole brain radiotherapy vs. a salvage SRS protocol in patients undergoing resection in 1-4 brain metastases
Gastrointestinal (Colorectal) Cancer
-Describe the benefit and toxicity of adding oxaliplatin with 5-FU and radiation in the preoperative setting for locally advanced rectal cancer
-Describe how HIV status impacts prognosis in patients with anal cancer
-Explain the impact of early versus late salvage surgery for patients who recur after chemoradiation for anal cancer
Gastrointestinal (Non-colorectal) Cancer
-Explain the role of radiotherapy after preoperative chemotherapy for gastric cancer
-Describe how stereotactic body radiotherapy compares to other liver-directed therapies
-Explain the optimal adjuvant therapy for resectable pancreatic cancer

Genitourinary (Prostate) Cancer

-Describe the added benefit of androgen deprivation in the setting of high dose radiation for localized prostate cancer.
-Assess the data investigating a moderately hypofractionated radiotherapy schedule relative to conventional fractionation
-Describe the role of adjuvant chemotherapy in high-risk prostate cancer patients' status post prostatectomy.
Thoracic
-Incorporate knowledge gained regarding how protons compare to photons for stage III non-small cell lung cancer (NSCLC) with respect to toxicity and tumor control
-Recognize the increasing use of stereotactic body radiation therapy (SBRT)/radiation/ local therapy for the management of metastatic lung cancer
-Recognize the benefits that radiation can offer for management of limited metastatic non-small cell lung cancer.
Melanoma
-Discuss immune checkpoint inhibition and its effect on long-term survival in metastatic melanoma
-Explain the effects of toxicity following immune checkpoint inhibition in metastatic melanoma
-Discuss combined targeted therapy and its effect on long-term survival in metastatic melanoma
Head and Neck Cancer
-Discuss how new agents and combinations can improve survival for metastatic head and neck cancer
-Recognize the risks associated with post-op organs, RT dose, timing, and need for concurrent chemotherapy
-Discuss the role of cetuxRT vs ChemoRT for locoregionally advanced disease.

Keywords

Radiation Oncology, Treatment Radiation, Management of Radiation, Radiation Techniques, Radiotherapy

Competencies

Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Academic Medicine, Inpatient, Outpatient, VA/Military

National Quality Strategies and/or Quadruple Aim Care Processes

Communication Skills, Evidence Based Practice, Interprofessional, Patient Safety/Medical Errors

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.